Browsing by Author 강혜진[강혜진]

Jump to:
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 8 of 8

Issue DateTitleAuthor(s)
2014-03Clinical features and treatment outcomes in patients with mantle cell lymphoma in Korea: Study by the consortium for improving survival of lymphoma김민경; 강병욱[강병욱]; 손상균[손상균]; 문준호[문준호]; 채이수[채이수]; 김종광[김종광]; 이수정[이수정]; 김원석[김원석]; 이제중[이제중]; 이세련[이세련]; 박건욱[박건욱]; 이호섭[이호섭]; 이원식[이원식]; 원종호[원종호]; 박무림[박무림]; 곽재용[곽재용]; 김호영[김호영]; 오성용[오성용]; 강혜진[강혜진]; 서철원[서철원]
2011-02Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone김민경; 김석진[김석진]; 강혜진[강혜진]; 김진석[김진석]; 오성용[오성용]; 최철원[최철원]; 이순일[이순일]; 원종호[원종호]; 권정혜[권정혜]; 서철원[서철원]; 김원석[김원석]
2011-02Immunoglobulin D multiple myeloma: response to therapy, survival, and prognostic factors in 75 patients김민경; 서철원[서철원]; 이대호[이대호]; 민창기[민창기]; 김석진[김석진]; 김기현[김기현]; 문준호[문준호]; 윤성수[윤성수]; 이경원[이경원]; 강혜진[강혜진]; 최철원[최철원]; 엄현석[엄현석]; 곽재용[곽재용]; 김효정[김효정]; 문영철[문영철]; 방수미[방수미]; 이기현[이기현]; 신효진[신효진]; 이재훈[이재훈]
2011-07Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL)김석진[김석진]; 김원석[김원석]; 김민경; 최철원[최철원]; 문영철[문영철]; 오성용[오성용]; 강혜진[강혜진]; 이순일[이순일]; 원종호[원종호]; 김진석[김진석]; 곽재용[곽재용]; 권정미[권정미]; 황인규[황인규]; 권정혜[권정혜]; 김효정[김효정]; 이재훈[이재훈]; 오석중[오석중]; 박건우[박건우]; 서철원[서철원]
2010-09Multiple mucosa-associated lymphoid tissue organs involving marginal zone B cell lymphoma: organ-specific relationships and the prognostic factors. Consortium for improving survival of lymphoma study김민경; 오성용[오성용]; 김원석[김원석]; 김진석[김진석]; 김석진[김석진]; 이수[이수]; 이대호[이대호]; 원종호[원종호]; 황인규[황인규]; 이순일[이순일]; 채이수[채이수]; 양덕환[양덕환]; 강혜진[강혜진]; 최철원[최철원]; 박지니[박지니]; 김효정[김효정]; 권정혜[권정혜]; 이호섭[이호섭]; 이경원[이경원]; 엄현석[엄현석]; 곽재용[곽재용]; 이원식[이원식]; 서철원[서철원]; 김효진[김효진]
2012-11S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for first-line treatment of patients with metastatic colorectal cancer: a randomised, non-inferiority phase 3 trial이경희; 홍용상[홍용상]; 박영숙[박영숙]; 임호영[임호영]; 김태원[김태원]; 김규표[김규표]; 김선영[김선영]; 백지연[백지연]; 김지현[김지현]; 이근욱[이근욱]; 정익주[정익주]; 조상희[조상희]; 신상준[신상준]; 강혜진[강혜진]; 신동복[신동복]; 조숙정[조숙정]; 이재원[이재원]
2010-09Stage IV marginal zone B-cell lymphoma - prognostic factors and the role of rituximab: Consortium for Improving Survival of Lymphoma (CISL) study김민경; 오성용[오성용]; 김원석[김원석]; 김진석[김진석]; 김석진[김석진]; 이수[이수]; 이대호[이대호]; 원종호[원종호]; 황인규[황인규]; 이순일[이순일]; 채이수[채이수]; 양덕환[양덕환]; 강혜진[강혜진]; 최철원[최철원]; 박지니[박지니]; 김효정[김효정]; 권정혜[권정혜]; 이호섭[이호섭]; 이경원[이경원]; 엄현석[엄현석]; 곽재용[곽재용]; 서철원[서철원]; 김효진[김효진]
2014-01Success Rate and Risk Factors for Failure of Empirical Antifungal Therapy with Itraconazole in Patients with Hematological Malignancies: A Multicenter, Prospective, Open-Label, Observational Study in Korea김수정[김수정]; 김진석[김진석]; 정철원[정철원]; 민유홍[민유홍]; 최영진[최영진]; 이동건[이동건]; 이제환[이제환]; 양덕환[양덕환]; 이상민[이상민]; 김성현[김성현]; 김양수[김양수]; 곽재용[곽재용]; 박진희[박진희]; 김진영[김진영]; 김훈구[김훈구]; 김병수[김병수]; 류헌모[류헌모]; 장준호[장준호]; 김민경; 강혜진[강혜진]; 조덕연[조덕연]; 김호영[김호영]; 박병배[박병배]

BROWSE